Changes in vaccination status, willingness and knowledge in patients with multiple sclerosis: Results from a five-year longitudinal study
4 affiliations
- 1Department of Neurology, Neuroimmunology Section, Rostock University Medical Center, Rostock, Germany.
- 2Department of Neurology, Ecumenic Hainich Hospital gGmbH, Mühlhausen, Germany.
- 3Faculty of Health Sciences, University of Hull, Hull, UK.
- 4Department of Neurology, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.
Abstract
Background: Multiple sclerosis (MS) is a chronic immune-mediated disease requiring long-term management. Both the disease itself and disease-modifying therapies increase susceptibility to severe infections. Ensuring adequate vaccination in patients with MS is therefore essential. However, vaccine hesitancy and suboptimal vaccination coverage remain major clinical challenges.
Objectives: To comprehensively evaluate changes in vaccination status, vaccination willingness and vaccination-related knowledge in patients with MS over a five-year interval spanning the pre-/early and post-pandemic periods of coronavirus disease 2019, and to identify factors associated with vaccination status and vaccine uptake.
Design: Longitudinal observational cohort study at a single German MS center.
Methods: Patients with MS (n=175) were assessed at baseline (August 2019 – June 2020) and follow-up (October 2024 – August 2025) using structured questionnaires and a review of vaccination records. The documented vaccination status for 26 vaccines was compared with patients’ self-reported vaccination status. Longitudinal changes and determinants of vaccination status were analyzed using paired statistical tests and logistic regression models.
Results: The patient cohort was predominantly female (70.3%) and had a mean age of 45.8 years and a median disease duration of 7 years at baseline. General vaccination willingness declined from 81.1% at baseline to 66.3% at follow-up (p=0.001). This occurred despite a marked increase in reported vaccination counseling within the past year (34.3% to 70.8%, p<0.001) and in vaccination monitoring by neurologists (5.7% to 47.7%, p<0.001). At follow-up, vaccination coverage was highest for tetanus (87.9%), diphtheria (84.7%) and poliomyelitis (84.3%). A pronounced self-awareness gap was observed: typically fewer than 50% of patients who believed they were protected had a complete vaccination status, e.g., for pneumococcal, herpes zoster, influenza and varicella. Vaccination-related concerns, including fear of side effects and MS worsening, were negatively associated with complete vaccination status or vaccine uptake, whereas prior influenza vaccination was positively associated.
Conclusion: Despite intensified vaccination counseling, vaccination willingness declined markedly, suggesting post-pandemic vaccination fatigue in patients with MS. Persistent discrepancies between perceived and documented vaccination status and the impact of vaccine-related concerns highlight the need for more targeted strategies to strengthen vaccination confidence and improve immunization coverage.
Related
- The role of socioeconomic status in HPV-related knowledge, attitude, vaccination willingness and preference among college males
- Association Between Local Ascending Aortic Elastic Properties and Left Ventricular Global Longitudinal Strain in Patients with Multiple Sclerosis: A Cross-Sectional Case–Control Echocardiographic Study
- Trust in HPV vaccine effectiveness and safety and willingness to initiate HPV vaccination among unvaccinated female college students recruited through university-based online networks in China: a cross-sectional study
- Cognitive and behavioral determinants of HPV vaccination willingness and Behavior among female university students in Karnataka, India.
- Multi-platform social media use and trust, health beliefs, and HPV vaccination willingness among Chinese university students
BibTeX
@article{barhoum2026changes,
title = {{Changes in vaccination status, willingness and knowledge in patients with multiple sclerosis: Results from a five-year longitudinal study}},
author = {Bassel Barhoum and Michael Hecker and Avinash Mohnish Suntah and Jonas Elias Langenberger and Julia Baldt and Barbara Streckenbach and Jörg Richter and Niklas Frahm and Felicita Heidler and Uwe Klaus Zettl},
journal = {Therapeutic Advances in Neurological Disorders},
year = {2026},
month = sep,
doi = {10.1177/17562864261476877},
url = {https://doi.org/10.1177/17562864261476877},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Changes in vaccination status, willingness and knowledge in patients with multiple sclerosis: Results from a five-year longitudinal study
AU - Bassel Barhoum
AU - Michael Hecker
AU - Avinash Mohnish Suntah
AU - Jonas Elias Langenberger
AU - Julia Baldt
AU - Barbara Streckenbach
AU - Jörg Richter
AU - Niklas Frahm
AU - Felicita Heidler
AU - Uwe Klaus Zettl
PY - 2026
DA - 2026/09/17
JO - Therapeutic Advances in Neurological Disorders
DO - 10.1177/17562864261476877
UR - https://doi.org/10.1177/17562864261476877
AB - Background: Multiple sclerosis (MS) is a chronic immune-mediated disease requiring long-term management. Both the disease itself and disease-modifying therapies increase susceptibility to severe infections. Ensuring adequate vaccination in patients with MS is therefore essential. However, vaccine hesitancy and suboptimal vaccination coverage remain major clinical challenges. Objectives: To comprehensively evaluate changes in vaccination status, vaccination willingness and vaccination-related knowledge in patients with MS over a five-year interval spanning the pre-/early and post-pandemic periods of coronavirus disease 2019, and to identify factors associated with vaccination status and vaccine uptake. Design: Longitudinal observational cohort study at a single German MS center. Methods: Patients with MS (n=175) were assessed at baseline (August 2019 – June 2020) and follow-up (October 2024 – August 2025) using structured questionnaires and a review of vaccination records. The documented vaccination status for 26 vaccines was compared with patients’ self-reported vaccination status. Longitudinal changes and determinants of vaccination status were analyzed using paired statistical tests and logistic regression models. Results: The patient cohort was predominantly female (70.3%) and had a mean age of 45.8 years and a median disease duration of 7 years at baseline. General vaccination willingness declined from 81.1% at baseline to 66.3% at follow-up (p=0.001). This occurred despite a marked increase in reported vaccination counseling within the past year (34.3% to 70.8%, p<0.001) and in vaccination monitoring by neurologists (5.7% to 47.7%, p<0.001). At follow-up, vaccination coverage was highest for tetanus (87.9%), diphtheria (84.7%) and poliomyelitis (84.3%). A pronounced self-awareness gap was observed: typically fewer than 50% of patients who believed they were protected had a complete vaccination status, e.g., for pneumococcal, herpes zoster, influenza and varicella. Vaccination-related concerns, including fear of side effects and MS worsening, were negatively associated with complete vaccination status or vaccine uptake, whereas prior influenza vaccination was positively associated. Conclusion: Despite intensified vaccination counseling, vaccination willingness declined markedly, suggesting post-pandemic vaccination fatigue in patients with MS. Persistent discrepancies between perceived and documented vaccination status and the impact of vaccine-related concerns highlight the need for more targeted strategies to strengthen vaccination confidence and improve immunization coverage.
SN - 1756-2856
SN - 1756-2864
ER -